Global Personalized Cancer Vaccine Market Size & Outlook
Global personalized cancer vaccine market, 2018-2030 (US$M)
Related Markets
Global personalized cancer vaccine market highlights
- The global personalized cancer vaccine market generated a revenue of USD 208.3 million in 2024 and is expected to reach USD 1,446.6 million by 2030.
- The market is expected to grow at a CAGR (2025 - 2030) of 44.9% by 2030.
- In terms of segment, dendritic cell accounted for a revenue of USD 226.7 million in 2024.
- Dendritic Cell is the most lucrative type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2024.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Global data book summary
| Market revenue in 2024 | USD 208.3 million |
| Market revenue in 2030 | USD 1,446.6 million |
| Growth rate | 44.9% (CAGR from 2025 to 2030) |
| Largest segment | Dendritic cell |
| Fastest growing segment | Dendritic Cell |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Dendritic Cell |
Other key industry trends
- In terms of revenue, the North America accounted for 34.1% of the global personalized cancer vaccine market in 2024.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 128.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Personalized Cancer Vaccine Market Scope
Personalized Cancer Vaccine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Nouscom | View profile | 11-50 | Basel, Basel-Stadt, Switzerland, Europe | https://nouscom.com/ |
| Imugene | View profile | 51-100 | Sydney, New South Wales, Australia, Oceania | https://www.imugene.com/ |
| Evaxion Biotech | View profile | 11-50 | Copenhagen, Hovedstaden, Denmark, Europe | http://evaxion-biotech.com/ |
| Elicio Therapeutics | View profile | 11-50 | Cambridge, Massachusetts, United States, North America | https://elicio.com |
| Stemirna | View profile | 11-50 | Beijing, Beijing, China, Asia | http://www.stemirna.com/ |
| Gritstone bio | View profile | 101-250 | Emeryville, California, United States, North America | https://gritstonebio.com |
| Dendreon | View profile | 1001-5000 | Seattle, Washington, United States, North America | http://www.dendreon.com/ |
| CureVac NV Ordinary Shares | View profile | 1100 | Friedrich-Miescher-Strasse 15, Tubingen, BW, Germany, 72076 | https://www.curevac.com |
Global personalized cancer vaccine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to personalized cancer vaccine market will help companies and investors design strategic landscapes.
Dendritic cell was the largest segment with a revenue share of 108.83% in 2024. Horizon Databook has segmented the Global personalized cancer vaccine market based on dendritic cell covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Personalized Cancer Vaccine Type Outlook (Revenue, USD Million, 2018-2030)
- Dendritic Cell
- RNA-Based (mRNA)
- Neoantigen-Based
- Tumor-Associated Antigen (TAA) Vaccines
- Global Personalized Cancer Vaccine Technology Outlook (Revenue, USD Million, 2018-2030)
- Cell based
- mRNA PCV
- Others
- Global Personalized Cancer Vaccine Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Clinics
- Research & Academic Institutes
Reasons to subscribe to Global personalized cancer vaccine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global personalized cancer vaccine market databook
-
Our clientele includes a mix of personalized cancer vaccine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global personalized cancer vaccine market , including forecasts for subscribers. This global databook contains high-level insights into Global personalized cancer vaccine market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global personalized cancer vaccine market size, by regions, 2018-2030 (US$M)
Top 10 countries: Personalized cancer vaccine market size, 2024 (US$M)
Global personalized cancer vaccine market share, by type, 2024 & 2030 (%, US$M)
Personalized cancer vaccine market: Opportunity assessment by country
Global personalized cancer vaccine market, by region, 2024 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
